Search results for: Naloxone

FDA Approves Drug to Counter Opioid ODs

Michele B. Kaufman, PharmD, BCGP | December 9, 2015

The FDA recently approved a form of naloxone hydrochloride in a nasal spray that will help counter opioid overdoses. The FDA also approved an ibuprofen injection as an adjunct to opioids for use in children 6 months and older…

Biosimilar for Infliximab Launched in Europe

Michele B. Kaufman, PharmD, BCGP | April 1, 2015

Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information

Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals

Michele B. Kaufman, PharmD, BCGP | October 1, 2014

Plus, rheumatology drug news, safety updates

Rheumatology Drug Updates

Michele D. Kaufman, PharmD, BSc, RPh | September 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Drug Updates

Michele B. Kaufman, PharmD, BCGP | November 1, 2010

Information on New Approvals and Medication Safety

« Previous Page
1
2
3